EC/EMA-FDA bilateral – update

Senior leadership from DG Health and Consumers (European Commission), the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) discussed a number of key initiatives at a bilateral meeting which took place in London from 31 March to 1 April 2014.
Participants discussed a broad range of issues, including drug supply-chain challenges and the creation of an EU-US Identification of Medicinal Products (IDMP) task force to explore the possibility of using and/or adapting the US new substances registration software for use in the EU, and to assess the feasibility of introducing global identification for medicinal products (EMA News Item, 22 April 2014).
Click here for the full EMA News Item.

This item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.